1.
Kamel AH, Abbas AA-H, Humadi YA. Impact of Interleukin-6 Serum Levels and rs1800795 Promoter Polymorphism on Disease Activity and Tumor Necrosis Factor Inhibitor Efficacy in Rheumatoid Arthritis . Al-Rafidain J Med Sci [Internet]. 2025 Jul. 27 [cited 2026 Jul. 5];9(1):118-26. Available from: https://www.ajms.iq/index.php/ALRAFIDAIN/article/view/2146